The tumor transplantation resulted in an increase in the levels of TNFα, LIF, IP-10, KC, IL-6, IL-7, IL-10, MCP-1, MIG, MIP-1α, VEGF, and G-CSF, as well as a decrease in the level of eotaxin. The gene discussed is CCL2; the disease is neoplasm.